Cargando…

Enriched circulating and tumor-resident TGF-β(+) regulatory B cells in patients with melanoma promote FOXP3(+) Tregs

B cells are emerging as key players of anti-tumor adaptive immune responses. We investigated regulatory and pro-inflammatory cytokine-expressing B cells in patients with melanoma by flow cytometric intracellular cytokine, CyTOF, transcriptomic, immunofluorescence, single-cell RNA-seq, and B:T cell c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harris, Robert J, Willsmore, Zena, Laddach, Roman, Crescioli, Silvia, Chauhan, Jitesh, Cheung, Anthony, Black, Anna, Geh, Jenny L. C., MacKenzie Ross, Alastair D, Healy, Ciaran, Tsoka, Sophia, Spicer, James, Lacy, Katie E, Karagiannis, Sophia N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336482/ https://www.ncbi.nlm.nih.gov/pubmed/35909944 http://dx.doi.org/10.1080/2162402X.2022.2104426

Ejemplares similares

Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies
por: Adams, Rebecca, et al.
Publicado: (2022)

B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies
por: Willsmore, Zena N., et al.
Publicado: (2021)

B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma
por: Crescioli, Silvia, et al.
Publicado: (2023)

IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype
por: Nakamura, Mano, et al.
Publicado: (2020)

Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4
por: Chauhan, Jitesh, et al.
Publicado: (2023)

Innate stimulation of B cells ex vivo enhances antibody secretion and identifies tumour-reactive antibodies from cancer patients
por: Karagiannis, Panagiotis, et al.
Publicado: (2021)

Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types
por: Ilieva, Kristina M., et al.
Publicado: (2018)

Foxp3 Molecular Dynamics in Treg in Juvenile Idiopathic Arthritis
por: Copland, Alastair, et al.
Publicado: (2018)

Clinical and Translational Significance of Basophils in Patients with Cancer
por: Chauhan, Jitesh, et al.
Publicado: (2022)

Induction of stable human FOXP3(+) Tregs by a parasite‐derived TGF‐β mimic
por: Cook, Laura, et al.
Publicado: (2021)

Novel drug-target interactions via link prediction and network embedding
por: Amiri Souri, E., et al.
Publicado: (2022)

Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma
por: Khair, Duaa O., et al.
Publicado: (2019)

Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3(+) Tregs
por: Chen, Xin, et al.
Publicado: (2021)

IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states
por: Pellizzari, Giulia, et al.
Publicado: (2019)

IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin
por: Saul, Louise, et al.
Publicado: (2016)

Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3(+) Tregs in follicular lymphoma
por: Nelson, Lilli S, et al.
Publicado: (2015)

Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade
por: Patel, Akshay J., et al.
Publicado: (2022)

Monitoring the Systemic Human Memory B Cell Compartment of Melanoma Patients for Anti-Tumor IgG Antibodies
por: Gilbert, Amy E., et al.
Publicado: (2011)

In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart
por: Man, Francis, et al.
Publicado: (2021)

FOXP3(+) Treg Cells and Gender Bias in Autoimmune Diseases
por: Nie, Jia, et al.
Publicado: (2015)

Foxp3(+) Tregs are recruited to the retina to repair pathological angiogenesis
por: Deliyanti, Devy, et al.
Publicado: (2017)

Foxp3 Post-translational Modifications and Treg Suppressive Activity
por: Deng, Guoping, et al.
Publicado: (2019)

Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments
por: McCraw, Alex J., et al.
Publicado: (2021)

The transcription factor Foxp1 preserves integrity of an active Foxp3 locus in extrathymic Treg cells
por: Ghosh, Sayantani, et al.
Publicado: (2018)

Changes in Natural Foxp3(+)Treg but Not Mucosally-Imprinted CD62L(neg)CD38(+)Foxp3(+)Treg in the Circulation of Celiac Disease Patients
por: van Leeuwen, Marieke A., et al.
Publicado: (2013)

PAK4 suppresses PDZ-RhoGEF activity to drive invadopodia maturation in melanoma cells
por: Nicholas, Nicole S., et al.
Publicado: (2016)

FOXP3 Promoter Demethylation Reveals the Committed Treg Population in Humans
por: Janson, Peter C. J., et al.
Publicado: (2008)

Stability and Maintenance of Foxp3(+) Treg Cells in Non-lymphoid Microenvironments
por: Korn, Thomas, et al.
Publicado: (2019)

Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications
por: Dong, Yi, et al.
Publicado: (2021)

Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells
por: Correa, Isabel, et al.
Publicado: (2018)

All-Trans Retinoic Acid Promotes TGF-β-Induced Tregs via Histone Modification but Not DNA Demethylation on Foxp3 Gene Locus
por: Lu, Ling, et al.
Publicado: (2011)

Cancer-FOXP3 directly activated CCL5 to recruit FOXP3(+)Treg cells in pancreatic ductal adenocarcinoma
por: Wang, X, et al.
Publicado: (2017)

Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes
por: Bax, Heather J., et al.
Publicado: (2022)

Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer
por: Harris, Robert J., et al.
Publicado: (2021)

Leprosy Reactions Show Increased Th17 Cell Activity and Reduced FOXP3+ Tregs with Concomitant Decrease in TGF-β and Increase in IL-6
por: Saini, Chaman, et al.
Publicado: (2016)

GATA3, HDAC6, and BCL6 Regulate FOXP3+ Treg Plasticity and Determine Treg Conversion into Either Novel Antigen-Presenting Cell-Like Treg or Th1-Treg
por: Xu, Keman, et al.
Publicado: (2018)

Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP
por: Elkord, Eyad, et al.
Publicado: (2015)

Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function
por: Huang, Jianbing, et al.
Publicado: (2017)

Foxp3 Instability Helps tTregs Distinguish Self and Non-self
por: Zhang, Zhongmei, et al.
Publicado: (2019)

Higher Sensitivity of Foxp3(+) Treg Compared to Foxp3(-) Conventional T Cells to TCR-Independent Signals for CD69 Induction
por: Bremser, Anna, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pokdhc2o3jh2d3fta7dg5igdqv